我要投票 伊可新在鱼肝油行业中的票数:277
· 外 推 电 报 ·
2025-05-11 11:29:13 星期日

【伊可新是哪个国家的品牌?】

伊可新是什么牌子?「伊可新」是 山东达因海洋生物制药股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人张璨在1994-10-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力伊可新品牌出海!将品牌入驻外推网,定制伊可新品牌推广信息,可以显著提高伊可新产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

“伊可新”属维生素类非处方药药品,宝宝出生15天开始,每天一粒,能有效预防和治疗维生素A及D的缺乏症,维生素d缺乏会引起佝偻病、小儿手足抽搐症,免疫力下降等,维生素A缺乏会引起机体免疫功能下降,易感性增加,腹泻和呼吸道感染发病率显著增加,还可增加缺铁性贫血发生率。伊可新有两种规格满足不同年龄宝宝每日营养所需,绿色伊可新(绿葫芦)适合0-1岁的宝宝,粉色伊可新(粉葫芦)适合1岁以上的宝宝;伊可新采用先进工艺、最佳科学配比保障了维生素AD的有效吸收,其精确的每天一粒剂量,以及香甜口味,是妈妈们放心的选择。

产品简介

药理作用:本品由维生素A及维生素D组成。维生素A和D是人体生长发育必需的物质,胎儿、婴幼儿的发育尤为重要,对保证上皮组织的完整性、视力、生殖器官、血钙和磷的恒定、骨骼、牙齿的生长发育等有重要作用,同时与机体的免疫功能也密切相关。

适应症:用于预防和治疗维生素A及D的缺乏症。如佝偻病、夜盲症及小儿手足抽搐症,可以促进钙吸收,增强抵抗力。

产品规格:0-1岁(绿色包装)每粒含1500国际单位维生素A,500国际单位维生素D3;1岁以上(红色包装)每粒含2000国际单位维生素A,700国际单位维生素D3。
用量用法

口服。将软囊滴嘴开口后,内容物滴入婴儿口中(开口方法:建议采用将滴嘴在开水中浸泡30秒,使胶皮融化;或采用干净的专用小剪子)。胶囊皮为可食用医用明胶制成,家长可根据孩子吞咽和咀嚼能力的情况,嚼服胶丸。1次1粒,1日1次。

山东达因海洋生物制药股份有限公司成立于1994年10月,是省级高新技术企业,主要从事儿童用药的研发、生产和销售,注册地在山东省荣成市。下设全资子公司北京达因康健医药有限责任公司和山东达因生物科技有限公司。

公司主要股东为山大华特科技股份有限公司、荣成市公有资产经营有限公司和中国医学科学院医药生物技术研究所等。其中山大华特科技股份有限公司是山东大学控股的山东省高校唯一上市公司(股票代码000915)。

公司现有产品主要涉及儿童药品和儿童保健食品领域,初步形成了以“儿童保健和治疗”为核心的儿童健康产业格局。儿童药品有伊可新(维生素AD滴剂胶囊型)、盖笛欣(复方碳酸钙泡腾颗粒剂)、伊甘欣(甘草锌颗粒剂)、右旋糖酐铁口服液等;儿童食品有益生菌粉、牛初乳咀嚼片、乳酸亚铁冲剂等。同时,公司产品还涉及内分泌、心血管、消化系统及抗感染等领域用药。

公司生产基地位于山东省荣成市开发区,占地300余亩,拥有软胶囊、硬胶囊、颗粒剂、片剂、口服液等多条现代化生产线及原料药车间。公司注重新产品、新技术研发和投入,积极开展省级研发平台建设,通过产学研合作,不断提高技术创新水平,以专业和责任捍卫儿童用药安全。

公司管理总部设在北京,销售网络遍及全国。在经营实践中,始终坚持“创新成就品牌,专业运作市场”的专业化推广方式,打造出了一支专业化素质高、执行力强的优秀团队,在业内赢得了广泛好评,多次获得省级荣誉称号。2010年达因®获山东省著名商标,旗下明星产品伊可新(维生素AD滴剂胶囊型)年销量突破4亿元、连续13年位居同类产品市场占有率第一。公司的销售收入、利润总额,根据2012年工信部公布的《中国医药统计年报》统计,位于全国化学制药工业前200强行列。

公司在取得良好经营业绩的同时,多年来一直积极参与社会公益和慈善事业,通过出资建设“达因希望小学”、参与西部贫困地区“我要上学”大型助学活动,以及向灾区、特困儿童等持续捐赠等多种形式回报社会,不断践行着达因人“使千千万万中国儿童健康强壮”的使命。


英文翻译:"Yi Ke Xin" is a kind of vitamin non prescription medicine. Starting from birth 15 days, hair coloring can effectively prevent and treat vitamin A and D deficiency. Vitamin D deficiency can cause rickets, infantile hand foot convulsion and immunity decline. Vitamin A deficiency can cause the decrease of immune function of the machine, increase the susceptibility, and increase the incidence of diarrhea and respiratory tract infection. It can increase the incidence of iron deficiency anemia. Icoxin has two specifications to meet the daily nutrition needs of babies of different ages. Green icoxin (green gourd) is suitable for babies aged 0-1, and pink icoxin (pink gourd) is suitable for babies over 1 year old. Icoxin adopts advanced technology and the best scientific ratio to ensure the effective absorption of vitamin ad. its accurate daily dose and sweet taste are safe choices for mothers 。 Pharmacological action: This product is composed of vitamin A and vitamin D. Vitamin A and vitamin D are essential substances for human growth and development, especially for the development of fetus and infants. They play an important role in ensuring the integrity of epithelial tissue, vision, reproductive organs, the constancy of blood calcium and phosphorus, the growth and development of bones and teeth, and are closely related to the immune function of the body. Indications: used to prevent and treat vitamin A and D deficiency. Such as rickets, night blindness and convulsions in children's hands and feet can promote calcium absorption and enhance resistance. Product specification: 0-1-year-old (green package) contains 1500 international units of vitamin A, 500 international units of vitamin D3; 1-year-old (red package) contains 2000 international units of vitamin A, 700 international units of vitamin D3. Take orally. After opening the mouth of the soft bag dripper, drop the contents into the baby's mouth (opening method: it is recommended to soak the dripper in boiling water for 30 seconds to melt the rubber; or use clean special scissors). The capsule skin is made of edible medical gelatin, and parents can chew and take the capsule according to their children's swallowing and chewing ability. One capsule once a day. Shandong dyne marine biopharmaceutical Co., Ltd. was founded in October 1994. It is a provincial high-tech enterprise, mainly engaged in the research, development, production and sales of children's drugs, registered in Rongcheng City, Shandong Province. It has two wholly-owned subsidiaries, Beijing dyne Health Medicine Co., Ltd. and Shandong dyne Biotechnology Co., Ltd. The main shareholders of the company are sunwater Technology Co., Ltd., Rongcheng City Public Assets Management Co., Ltd. and Institute of pharmaceutical biotechnology, Chinese Academy of Medical Sciences, etc. Shanda Huate Technology Co., Ltd. is the only listed company (Stock Code: 000915) in Shandong Province, which is controlled by Shandong University. The company's existing products mainly involve children's medicine and children's health food, and has initially formed a children's health industry pattern with "children's health care and treatment" as the core. Children's medicines include ikosin (vitamin AD drop capsule), gedixin (compound calcium carbonate effervescent granules), iganxin (Glycyrrhiza zinc granules), dextran iron oral liquid, etc.; children's food includes probiotic powder, Bovine Colostrum Chewable Tablets, ferrous lactate granules, etc. At the same time, the company's products are also involved in endocrine, cardiovascular, digestive system and anti infection and other fields. The company's production base is located in Rongcheng Development Zone, Shandong Province, covering an area of more than 300 mu, with a number of modern production lines and API workshops such as soft capsule, hard capsule, granule, tablet, oral liquid, etc. The company pays attention to the research and development and investment of new products and technologies, actively carries out the construction of provincial research and development platform, continuously improves the level of technological innovation through the cooperation of production, education and research, and defends the safety of children's drug use with professional and responsibility. The company is headquartered in Beijing, with sales network throughout the country. In the business practice, we always adhere to the professional promotion mode of "innovation makes brand, professional operation market", and have created an excellent team with high professional quality and strong execution, which has won wide praise in the industry and won provincial honorary titles for many times. In 2010, dyne ® won the famous trademark of Shandong Province, and its star product icoxin (vitamin AD drops capsule type) has an annual sales volume of more than 400 million yuan, ranking first in the market share of similar products for 13 consecutive years. The total sales revenue and profit of the company are in the top 200 of the national chemical pharmaceutical industry according to the statistics of China Pharmaceutical statistics annual report published by the Ministry of industry and information technology in 2012. While achieving good business performance, the company has been actively participating in social public welfare and philanthropy for many years. By investing in the construction of "dyne hope primary school", participating in large-scale "I want to go to school" learning activities in western poverty-stricken areas, and continuing to donate to the disaster areas, especially poor children and other forms, the company has been constantly practicing "making thousands of Chinese children healthy and strong" Strong "mission.

本文链接: https://www.waitui.com/brand/aa4d7e6ca.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

长春光机所光电突触器件研究取得新进展

中国科学院长春光学精密机械与物理研究所(下称“长春光机所”)的科研人员开发出一种紫外光电突触器件和一种光电突触晶体管,这两项成果分别为先进人工视觉系统和神经形态计算视觉的发展提供了新的技术路径。紫外光电突触器件由长春光机所特种发光科学与技术全国重点实验室黎大兵、孙晓娟研究员领导的研究团队成功开发。(e公司)

2小时前

我国科学家实现基于主动光学强度干涉的合成孔径成像

中国科学技术大学潘建伟、张强、徐飞虎等人联合美国麻省理工学院、中国科学院西安光学精密机械研究所等单位,首次提出并实验验证了主动光学强度干涉技术合成孔径技术,实现了对1.36公里外毫米级目标的高分辨成像。实验系统的成像分辨率较干涉仪中的单台望远镜提升约14倍。该成果5月9日在国际学术期刊《物理评论快报》发表。(财联社)

2小时前

海光信息杨鸿轩:医疗国产化进入实战期,好用比性能更重要

36氪获悉,在CHIMA 2025大会现场,海光信息副总裁杨鸿轩表示,医疗行业信息化进入实战阶段,对底层算力平台的要求不仅是性能强,更要“好用”和“易用”。海光高度重视生态链建设,联合超5000家产业链伙伴,从芯片、整机到操作系统、数据库、应用软件,构建了完整的产业生态体系,推动全场景应用适配。杨鸿轩指出,医疗行业专业信息化人手紧张,对平台“无感迁移”和“一站式支撑”的需求更高。他强调,海光将持续加大在医疗国产化领域的投入,携手生态伙伴深化技术协同与应用优化,助力医院构建稳健、高效的国产化信息系统基础。

2小时前

英诺赛科在与英飞凌的专利诉讼中获得管辖权胜诉

据悉,中国第三代半导体企业英诺赛科与国际芯片巨头英飞凌的专利诉讼有新进展,最高人民法院终审裁定,驳回英飞凌中国公司及无锡公司提出的管辖权异议上诉,确认苏州市中级人民法院对案件的管辖权。2025年1月,英诺赛科(苏州)科技股份有限公司公告,公司及全资附属公司起诉英飞凌中国公司、英飞凌无锡公司及芯沃科公司专利侵权。英飞凌方提出管辖权异议,但被苏州中院一审驳回。之后英飞凌上诉至最高人民法院。(科创板日报)

2小时前

常见故障100%识别 我国货运铁路首套智能巡检机器人投用

5月11日,从国家能源集团获悉,我国货运铁路首套智能巡检机器人在河北沧州投用,这对促进我国铁路货车智能化水平提升具有重要示范意义。此次投入使用的智能巡检机器人组在我国铁路货车检修领域首次实现“机器人巡检+人工复核+云端诊断”多运维模式。这套智能巡检机器大幅减少人工巡检的劳动强度和人为误差,检修故障识别准确率大于98%,对于常见故障的识别率100%。(财联社)

2小时前

本页详细列出关于伊可新的品牌信息,含品牌所属公司介绍,伊可新所处行业的品牌地位及优势。
咨询